Geode Capital Management LLC Has $28.40 Million Stake in Phreesia, Inc. (NYSE:PHR)

Geode Capital Management LLC lifted its holdings in shares of Phreesia, Inc. (NYSE:PHR) by 4.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,245,797 shares of the company’s stock after acquiring an additional 55,934 shares during the quarter. Geode Capital Management LLC owned approximately 2.16% of Phreesia worth $28,397,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. M&T Bank Corp lifted its holdings in Phreesia by 4.6% during the 3rd quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock valued at $801,000 after purchasing an additional 1,535 shares during the last quarter. Barclays PLC raised its position in shares of Phreesia by 83.6% in the third quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after purchasing an additional 43,225 shares during the period. XTX Topco Ltd acquired a new stake in shares of Phreesia during the 3rd quarter worth about $247,000. Zacks Investment Management bought a new stake in shares of Phreesia during the 3rd quarter worth about $631,000. Finally, State Street Corp grew its stake in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after buying an additional 88,517 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PHR has been the subject of several research reports. Royal Bank of Canada restated a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a report on Friday, September 27th. DA Davidson reissued a “buy” rating and set a $32.00 price target on shares of Phreesia in a report on Thursday, September 5th. Robert W. Baird decreased their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Needham & Company LLC reissued a “buy” rating and set a $29.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Finally, Truist Financial upped their price target on shares of Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, Phreesia has a consensus rating of “Moderate Buy” and a consensus target price of $29.33.

Phreesia Price Performance

Phreesia stock opened at $25.76 on Friday. The firm has a market cap of $1.50 billion, a P/E ratio of -17.52 and a beta of 0.98. The stock’s 50 day moving average is $21.18 and its 200 day moving average is $22.12. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same period last year, the business posted ($0.58) EPS. The business’s revenue was up 16.6% compared to the same quarter last year. As a group, research analysts expect that Phreesia, Inc. will post -1.16 EPS for the current year.

Insider Buying and Selling

In other Phreesia news, General Counsel Allison C. Hoffman sold 3,495 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total value of $86,955.60. Following the completion of the sale, the general counsel now directly owns 116,296 shares of the company’s stock, valued at approximately $2,893,444.48. This represents a 2.92 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Amy Beth Vanduyn sold 25,447 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $20.93, for a total value of $532,605.71. Following the completion of the transaction, the senior vice president now owns 93,470 shares in the company, valued at $1,956,327.10. The trade was a 21.40 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 90,342 shares of company stock worth $2,041,225 in the last quarter. Insiders own 5.80% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.